Nexalin Technology Total Liabilities 2021-2025 | NXL
Nexalin Technology total liabilities from 2021 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Nexalin Technology Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $1 |
| 2023 | $0 |
| 2022 | $2 |
| 2021 | $2 |
| 2020 | $2 |
| Nexalin Technology Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1 |
| 2024-12-31 | $1 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $1 |
| 2023-12-31 | $0 |
| 2023-09-30 | $1 |
| 2023-06-30 | $1 |
| 2023-03-31 | $1 |
| 2022-12-31 | $2 |
| 2022-09-30 | $2 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | |
| 2021-09-30 | $0 |
| 2020-12-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Business Services | Technology Services | $0.015B | $0.000B |
| Nexalin Technology Inc. designs and develops neurostimulation products for mental health epidemic. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. Nexalin Technology Inc. is based in Houston, Texas. | |||